Preliminary Study of Feasibility of Arthrodesis Scapula-humeral Under Arthroscopy

Arthroscopy Arthrodesis Gleno-humeral Clinical Trial

— DESEP  

Official title:

Arthrodesis Gleno Humeral Under Arthroscopy in the Sequelae of Plexus Brachial Evaluation of the Technical Feasibility

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02566382
• Other study ID #: RB 12.172 DESEP
• Status: Terminated
• Phase: N/A
• First received: September 29, 2015
• Last updated: October 18, 2017
• Start date: September 2015
• Est. completion date: October 2017

Study information

• Verified date: October 2017
• Source: University Hospital, Brest
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Arthrodesis shoulder blade/humerus under arthroscopy. Implementation of an external fixative spray at the proximal level in the thorn of the scapula and distal in the diaphysis humerus.

Description:

This trial is about the arthrodesis shoulder blade/humerus under arthroscopy. The main aim of this study is to be able to carry out a fusion scapula-humeral supplements in 6 months. It is required to provide the benefice risk over to reduce the hospitalisation 48 hours.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 1
• Est. completion date: October 2017
• Est. primary completion date: October 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patient having a deficit scapula-humeral mobility

• Impossibility of being operated for a preserving nervous surgery

• Patient affiliation with a social security

• Patient who signed inform consent

Exclusion Criteria:

• Patient with No mobility in all the articulations of the shoulder

• Callus malunion of the higher end of the humerus or the glen of the scapula

• Unable to sign an inform consent

Related Conditions & MeSH terms

• Arthroscopy Arthrodesis Gleno-humeral

Intervention

Procedure:
• arthroscopy arthrodesis of the shoulder
The shoulder surgery will be realized under arthroscopy only

Locations

Country	Name	City	State
France	Brest university hospital	Brest	Bretagne

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Radiological fusion gleno humeral on side and front view after the 6th month of the arthroscopy interventional	This outcome will be considered like a success if the investigators get a continuous bone matrix between the humeral head and glenoid on the scapula and bone frame continues between the humeral head and the acromion. This evaluation will be done by radiographies.	6 months
Secondary	Blood loss	The blood loss during and after the surgery will be calculated and will be considered like a success if the total blood loss are less than 600ml.	3 days